Related Experiment Video
Updated: Jan 17, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Updating the PRISMA reporting guideline for network meta-analysis: a scoping review
Areti Angeliki Veroniki1, Andrea C Tricco2, Daniella Rangira3
1Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, Ontario, Canada; Institute for Health Policy, Management, and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario, Canada; Center for Evidence Synthesis in Health, Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA.
Background And Objective:
This scoping review is the first step in the process of updating the 2015 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for network meta-analysis (NMA). It builds up on a 2014 scoping review by our team and aims to enhance the usability, completeness, and transparency of NMA reporting for diverse audiences, including patients and the public. The updated extension will align with PRISMA 2020 and will address gaps in reporting, such as documenting methods for assessing NMA homogeneity and transitivity, defining intervention nodes in a network of studies, and considering advances in statistical modeling with NMA.
Methods:
We registered the study protocol with the Open Science Framework and published it in Joanna Briggs Institute (JBI) Evidence Synthesis. We searched multiple databases and gray literature sources, and screened studies in duplicate. Data extraction was also conducted in duplicate using a standardized form, focusing on study characteristics, authors' reporting recommendations, and proposed additions to PRISMA-NMA and/or PRISMA 2020.
Results:
Sixty-one studies met eligibility criteria, including 23 guidance documents and 38 overviews of reviews assessing the completeness or quality of NMA reporting. We identified 37 additional reporting items relevant to NMAs, which will inform the next stage of the PRISMA-NMA update (a Delphi consensus process).
Conclusion:
Our findings support the urgent need to update the PRISMA-NMA guideline. Addressing persistent reporting gaps and incorporating recent methodological developments is critical to improving the transparency, reproducibility, and trustworthiness of NMAs.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
06:26Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI
Published on: November 27, 2019
Related Concept Videos
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Bias in Epidemiological Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials: Overview
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Statistical Methods for Analyzing Epidemiological Data